HLX BCR-ABL by RT-PCR CASE HLX BCR-ABL by RT-PCR CASE
Synonyms |
|
Allscripts (AEHR) Order Name |
BCR/ABL Quantitative |
Sunrise Clinical Manager (SCM) Order Name |
Not Orderable |
EPIC Order Name |
|
Clinical Info |
CML is a myeloproliferative disorder characterized by the presence of the Philadelphia (Ph) chromosome. This chromosome is the product of t (9; 22), a reciprocal translocation between the long arms of chromosomes 9 and 22. The corresponding fusion gene, BCR-ABL1, is transcribed into an 8.5 KB mRNA, with 2 junction variants b2a2 (40% of cases) and b3a2 (55% of cases). The b2a3 and b3a3 transcripts represent less than 5% of cases. The fusion gene encodes for a chimeric protein, p210, with elevated tyrosine kinase activity. |
Specimen Type |
Blood, Bone Marrow |
Container |
Lavender Top Tube |
Collection Instructions |
Peripheral Blood or Bone Marrow |
Transport Instructions |
Refrigerated |
Specimen Stability |
3 days Refrigerated |
Methodology |
Real-Time Polymerase Chain Reaction (PCR) |
Days Performed |
Monday through Friday |
Performing Laboratory |
Northwell Health Laboratories |
CPT |
81206 - for p210 (Major) |
PDM |
5911120 |
Result InterpretationAn interpretative report will be provided. |
|
Forms |
